Viability of Whole‐Slide Imaging for Intraoperative Touch Imprint Cytological Diagnosis of Axillary Sentinel Lymph Nodes in Breast Cancer Patients
Diagnostic Cytopathology · 2025
DOI: 10.1002/dc.25401 ↗At a glance
Journal article in Diagnostic Cytopathology, 2025. Written by Fei Ren and 10 co-authors. Institution: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Major MEDLINE topics: Breast Neoplasms, Sentinel Lymph Node, Sentinel Lymph Node Biopsy, Axilla. Cited 3 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Shanghai Municipal Key Clinical Specialty, Shanghai Science and Technology Development Fund, Shanghai Science and Technology Development Foundation.
Topics: Onkologische Pflege
Abstract (original language)
Background
Whole‐slide imaging (WSI) is a promising tool in pathology. However, the use of WSI in cytopathology has lagged behind that in histology. We aimed to evaluate the utility of WSI for the intraoperative touch imprint cytological diagnosis of axillary sentinel lymph nodes (SLNs) in breast cancer patients.
Methods
Glass slides from touch imprint cytology of 480 axillary SLNs were scanned using two different WSI scanners. The intra‐ and interobserver concordance, accuracy, possible reasons for misdiagnosis, scanning time, and review time for three cytopathologists were compared between WSI and light microscopy (LM).
Results
A total of 4320 diagnoses were obtained. There was substantial to strong intraobserver concordance when comparing reads among paired LM slides and WSI digital slides (κ coefficient ranged from 0.63 to 0.88, and concordance rates ranged from 94.58% to 98.33%). Substantial to strong interobserver agreement was also observed among the three cytopathologists (κ coefficient ranged from 0.67 to 0.85, and concordance rates ranged from 95.42% to 97.92%). The accuracy of LM was slightly higher (average of 98.06%) than that of WSI (averages of 96.81% and 97.78%). The majority of misdiagnoses were false negative diagnoses due to the following top three causes: few cancer cells, confusing cancer cells with histiocytes, and confusing cancer cells with lymphocytes.
Conclusions
This study is the first to address the feasibility of WSI in touch imprint cytology. The use of WSI for intraoperative touch imprint cytological diagnosis of SLNs is a practical option when experienced staff are not available on‐site.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Pediatric Clinical Research Unit, Department of Research Management, Children's Hospital of Fudan University, Shanghai, China.
- Center for Evidence-Based Medicine, Fudan University, Shanghai, China.
ORCID profiles: Xiaochun Wan, Yanli Wang
Funding
- Shanghai Municipal Key Clinical Specialty
- Shanghai Science and Technology Development Fund
- Shanghai Science and Technology Development Foundation
Cite
APA
Ren, F., Li, H., Yang, W., Chen, Y., Zheng, Y., Zhang, H., Zhou, S., Ping, B., Shi, P., Wan, X., & Wang, Y. (2025). Viability of Whole‐Slide Imaging for Intraoperative Touch Imprint Cytological Diagnosis of Axillary Sentinel Lymph Nodes in Breast Cancer Patients. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25401
Vancouver
Ren F, Li H, Yang W, Chen Y, Zheng Y, Zhang H, et al. Viability of Whole‐Slide Imaging for Intraoperative Touch Imprint Cytological Diagnosis of Axillary Sentinel Lymph Nodes in Breast Cancer Patients. Diagnostic Cytopathology. 2025. doi:10.1002/dc.25401
BibTeX
@article{Ren2025,
author = {Ren, Fei and Li, Huange and Yang, Wentao and Chen, Ying and Zheng, Yuwei and Zhang, Hao and Zhou, Shuling and Ping, Bo and Shi, Peng and Wan, Xiaochun and Wang, Yanli},
title = {Viability of Whole‐Slide Imaging for Intraoperative Touch Imprint Cytological Diagnosis of Axillary Sentinel Lymph Nodes in Breast Cancer Patients},
journal = {Diagnostic Cytopathology},
year = {2025},
doi = {10.1002/dc.25401}
}
EUVIMED